Oncology

A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) using a blood test based on tRNA signatures.

Researchers analyzed over 6,500 treatment episodes between January 2017 and December 2020, with follow-up through June 2024

A new bispecific antibody therapy, AFM28, has shown strong preclinical results in targeting treatment-resistant cells in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS), according to new research.

A new review highlights the growing role of fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.  

A new AI model, AAnet, reveals that tumours are made up of a continuum of functional cell states. It identifies GLUT3 as a key driver of metastasis.

A new study from Ireland shows that neoadjuvant chemoradiation is safe and effective in older adults with oesophageal cancer, with no survival disadvantage versus younger patients.

Researchers in Germany have developed HANCOCK, a comprehensive dataset of head and neck cancer cases, to support biomarker discovery and precision oncology.

At least 60% of liver cancer diagnoses are linked to modifiable risk factors and could be prevented through global interventions